Correspondence to editorial on "GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers".
作者信息
Li Yi-Tong, Shao Wei-Qing, Chen Zhen-Mei, Lin Jing, Chen Jin-Hong
机构信息
Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China.
出版信息
Clin Mol Hepatol. 2025 Apr;31(2):e186-e188. doi: 10.3350/cmh.2025.0079. Epub 2025 Jan 24.
Abstract
摘要
相似文献
1
Correspondence to editorial on "GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers".致关于“GOLM1通过ABCG5介导的胆固醇外流促进MASH肝脏中胆固醇结石形成”的社论的信函。
Clin Mol Hepatol. 2025 Apr;31(2):e186-e188. doi: 10.3350/cmh.2025.0079. Epub 2025 Jan 24.
2
GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in metabolic dysfunction-associated steatohepatitis livers.高尔基体膜蛋白1（GOLM1）通过ABCG5介导的胆固醇外流促进代谢功能障碍相关脂肪性肝炎肝脏中胆固醇胆结石的形成。
Clin Mol Hepatol. 2025 Apr;31(2):409-425. doi: 10.3350/cmh.2024.0657. Epub 2024 Dec 10.
3
Bridging the gap: The GOLM1-OPN-ABCG5 axis in MASH and gallstone disease: Editorial on "GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers".弥合差距：MASH和胆结石疾病中的GOLM1-OPN-ABCG5轴：关于“GOLM1通过ABCG5介导的MASH肝脏中胆固醇流出促进胆固醇胆结石形成”的社论
Clin Mol Hepatol. 2025 Apr;31(2):631-634. doi: 10.3350/cmh.2025.0066. Epub 2025 Feb 3.
4
Unraveling the role of GOLM1-OPN-ABCG5 axis in MASH: Editorial on "GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers".解析高尔基蛋白73-骨桥蛋白-ATP结合盒转运体G5轴在代谢相关脂肪性肝病中的作用：关于“高尔基蛋白73通过ABCG5介导的代谢相关脂肪性肝病肝脏胆固醇流出促进胆固醇胆结石形成”的述评
Clin Mol Hepatol. 2025 Apr;31(2):628-630. doi: 10.3350/cmh.2025.0036. Epub 2025 Jan 16.
5
GOLM1 and bile acid synthesis: Correspondence to editorial on "GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers".GOLM1与胆汁酸合成：与关于“GOLM1通过ABCG5介导的MASH肝脏胆固醇流出促进胆固醇胆结石形成”的社论的对应关系
Clin Mol Hepatol. 2025 Apr;31(2):e189-e191. doi: 10.3350/cmh.2025.0120. Epub 2025 Feb 13.
6
Reply to correspondence 1 on "GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers".对关于“GOLM1通过ABCG5介导的胆固醇外排促进MASH肝脏中胆固醇结石形成”的通信1的回复
Clin Mol Hepatol. 2025 Apr;31(2):e226-e227. doi: 10.3350/cmh.2025.0128. Epub 2025 Feb 13.
7
Reply to correspondence 2 on "GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers".对关于“GOLM1通过ABCG5介导的胆固醇外流促进MASH肝脏中胆固醇胆结石形成”的通信2的回复
Clin Mol Hepatol. 2025 Apr;31(2):e228-e231. doi: 10.3350/cmh.2025.0195. Epub 2025 Feb 26.
8
The ABCG5/8 cholesterol transporter and myocardial infarction versus gallstone disease.ABCG5/8 胆固醇转运蛋白与心肌梗死和胆石病。
J Am Coll Cardiol. 2014 May 27;63(20):2121-2128. doi: 10.1016/j.jacc.2013.12.055. Epub 2014 Mar 19.
9
Evidence that the adenosine triphosphate-binding cassette G5/G8-independent pathway plays a determinant role in cholesterol gallstone formation in mice.三磷酸腺苷结合盒转运体G5/G8非依赖途径在小鼠胆固醇性胆结石形成中起决定性作用的证据。
Hepatology. 2016 Sep;64(3):853-64. doi: 10.1002/hep.28570. Epub 2016 Jun 3.
10
Recent Advances in the Critical Role of the Sterol Efflux Transporters ABCG5/G8 in Health and Disease.甾醇外排转运蛋白 ABCG5/G8 在健康和疾病中的关键作用的最新进展。
Adv Exp Med Biol. 2020;1276:105-136. doi: 10.1007/978-981-15-6082-8_8.
引用本文的文献
1
Reply to correspondence 1 on "GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers".对关于“GOLM1通过ABCG5介导的胆固醇外排促进MASH肝脏中胆固醇结石形成”的通信1的回复
Clin Mol Hepatol. 2025 Apr;31(2):e226-e227. doi: 10.3350/cmh.2025.0128. Epub 2025 Feb 13.
本文引用的文献
1
Unraveling the role of GOLM1-OPN-ABCG5 axis in MASH: Editorial on "GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers".解析高尔基蛋白73-骨桥蛋白-ATP结合盒转运体G5轴在代谢相关脂肪性肝病中的作用：关于“高尔基蛋白73通过ABCG5介导的代谢相关脂肪性肝病肝脏胆固醇流出促进胆固醇胆结石形成”的述评
Clin Mol Hepatol. 2025 Apr;31(2):628-630. doi: 10.3350/cmh.2025.0036. Epub 2025 Jan 16.
2
GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in metabolic dysfunction-associated steatohepatitis livers.高尔基体膜蛋白1（GOLM1）通过ABCG5介导的胆固醇外流促进代谢功能障碍相关脂肪性肝炎肝脏中胆固醇胆结石的形成。
Clin Mol Hepatol. 2025 Apr;31(2):409-425. doi: 10.3350/cmh.2024.0657. Epub 2024 Dec 10.
3
A researcher's guide to preclinical mouse NASH models.临床前小鼠非酒精性脂肪性肝炎（NASH）模型研究指南
Nat Metab. 2022 Dec;4(12):1632-1649. doi: 10.1038/s42255-022-00700-y. Epub 2022 Dec 20.
4
Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver disease.饮食与营养治疗非酒精性脂肪性肝病。
Clin Mol Hepatol. 2023 Feb;29(Suppl):S244-S260. doi: 10.3350/cmh.2022.0364. Epub 2022 Dec 14.
5
Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis.非酒精性脂肪性肝炎及其纤维化的发病机制与治疗。
Clin Mol Hepatol. 2023 Jan;29(1):77-98. doi: 10.3350/cmh.2022.0237. Epub 2022 Oct 13.
6
Cholesterol suppresses GOLM1-dependent selective autophagy of RTKs in hepatocellular carcinoma.胆固醇抑制肝癌细胞中 GOLM1 依赖性 RTKs 的选择性自噬。
Cell Rep. 2022 Apr 19;39(3):110712. doi: 10.1016/j.celrep.2022.110712.
7
GOLM1 restricts colitis and colon tumorigenesis by ensuring Notch signaling equilibrium in intestinal homeostasis.GOLM1 通过确保肠道稳态中的 Notch 信号平衡来限制结肠炎和结肠肿瘤发生。
Signal Transduct Target Ther. 2021 Apr 14;6(1):148. doi: 10.1038/s41392-021-00535-1.
8
Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development.雌激素相关受体α依赖性肝 VLDL 分泌功能障碍导致 NAFLD/NASH 发展的性别差异。
Theranostics. 2020 Aug 29;10(24):10874-10891. doi: 10.7150/thno.47037. eCollection 2020.
9
Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis.女性患非酒精性脂肪性肝病的风险较低，但进展为该病的风险高于男性：系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2021 Jan;19(1):61-71.e15. doi: 10.1016/j.cgh.2020.04.067. Epub 2020 Apr 30.
10
Recent research trends and updates on nonalcoholic fatty liver disease.非酒精性脂肪性肝病的最新研究趋势和进展。
Clin Mol Hepatol. 2019 Mar;25(1):1-11. doi: 10.3350/cmh.2018.0037. Epub 2018 Aug 8.
Zotero 插件